You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Colorcon
Medtronic
Moodys
Boehringer Ingelheim

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Neomycin sulfate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for neomycin sulfate and what is the scope of freedom to operate?

Neomycin sulfate is the generic ingredient in thirteen branded drugs marketed by Pharmacia And Upjohn, X Gen Pharms, Pfizer, Bristol Myers Squibb, Lannett, Lannett Co Inc, Lilly, Nostrum Labs Inc, Roxane, Sandoz, Teva, Xgen Pharms, Glaxosmithkline, Alcon, Watson Labs, Monarch Pharms, Allergan, Merck, Savage Labs, Fougera, and Pharmaderm, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for neomycin sulfate. Four suppliers are listed for this compound.

Recent Clinical Trials for neomycin sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 4
Ache Laboratorios Farmaceuticos S.A.Phase 3
European CommissionPhase 2

See all neomycin sulfate clinical trials

Pharmacology for neomycin sulfate
Medical Subject Heading (MeSH) Categories for neomycin sulfate

US Patents and Regulatory Information for neomycin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide CREAM;TOPICAL 062600-001 Jul 21, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Xgen Pharms NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065220-001 Jul 28, 2006 AA RX No No   Start Trial   Start Trial   Start Trial
Watson Labs NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 062664-001 Apr 8, 1986 AT RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 204435-001 Jun 10, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
Roxane NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 062173-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE neomycin sulfate; triamcinolone acetonide OINTMENT;TOPICAL 062608-001 May 23, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
X Gen Pharms NEO-FRADIN neomycin sulfate SOLUTION;ORAL 065010-001 May 23, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
McKinsey
Baxter
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.